BlackRock Fund Advisors’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-7,374
| Closed | -$4K | – | 4328 |
|
|
2016
Q3 | $4K | Buy |
7,374
+804
| +12% | +$436 | ﹤0.01% | 4124 |
|
|
2016
Q2 | $4K | Sell |
6,570
-1,346,742
| -100% | -$820K | ﹤0.01% | 4157 |
|
|
2016
Q1 | $1.98M | Buy |
1,353,312
+58,481
| +5% | +$85.4K | ﹤0.01% | 3083 |
|
|
2015
Q4 | $4.14M | Buy |
1,294,831
+67,024
| +5% | +$214K | ﹤0.01% | 2929 |
|
|
2015
Q3 | $7.67M | Buy |
1,227,807
+6,847
| +0.6% | +$42.8K | ﹤0.01% | 2532 |
|
|
2015
Q2 | $12.1M | Buy |
1,220,960
+20,909
| +2% | +$208K | ﹤0.01% | 2395 |
|
|
2015
Q1 | $8.84M | Buy |
1,200,051
+130,021
| +12% | +$958K | ﹤0.01% | 2507 |
|
|
2014
Q4 | $5.73M | Buy |
1,070,030
+214,493
| +25% | +$1.15M | ﹤0.01% | 2800 |
|
|
2014
Q3 | $4.3M | Sell |
855,537
-21,046
| -2% | -$106K | ﹤0.01% | 2839 |
|
|
2014
Q2 | $5.88M | Buy |
876,583
+789,219
| +903% | +$5.3M | ﹤0.01% | 2746 |
|
|
2014
Q1 | $633K | Buy |
87,364
+10,593
| +14% | +$76.8K | ﹤0.01% | 3230 |
|
|
2013
Q4 | $289K | Buy |
76,771
+16,498
| +27% | +$62.1K | ﹤0.01% | 3331 |
|
|
2013
Q3 | $203K | Buy |
60,273
+4,734
| +9% | +$15.9K | ﹤0.01% | 3381 |
|
|
2013
Q2 | $186K | Buy |
+55,539
| New | +$186K | ﹤0.01% | 3350 |
|